Trial Profile
The effects of Teneligliptin on endothelial function in type 2 diabetes mellitus with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 21 Apr 2015 New trial record